Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 16, 2021 16:05 ET | Source: NanoVibronix, Inc.

NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business Update

ELMSFORD, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable...
April 01, 2020 08:00 ET | Source: NanoVibronix, Inc.

NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield™

ELMSFORD, N.Y., April 01, 2020 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic...
March 27, 2020 09:41 ET | Source: NanoVibronix, Inc.

NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis

ELMSFORD, N.Y., March 27, 2020 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic...
June 24, 2019 17:42 ET | Source: NanoVibronix, Inc.

NanoVibronix Announces Closing of $3.2 Million Private Placement

ELMSFORD, N.Y., June 24, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the...
June 05, 2019 08:30 ET | Source: NanoVibronix, Inc.

NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect

Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain NanoVibronix partnering with Saralex Group for regulatory...
February 25, 2019 08:00 ET | Source: NanoVibronix, Inc.

NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research

55.2% improvement in baseline pain scores versus 2.3% for the control group 46.4% reduction in breakthrough pain medication, including opioids, versus 1.5% versus for the treatment group PainShield™...
January 11, 2019 08:00 ET | Source: NanoVibronix, Inc.

NanoVibronix Enters Collaboration Agreement with Fritz Clinic to Offer PainShield® as an Alternative to Opioids for Pain Management

ELMSFORD, N.Y., Jan. 11, 2019 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
December 27, 2018 08:00 ET | Source: NanoVibronix, Inc.

NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel

ELMSFORD, N.Y., Dec. 27, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
December 20, 2018 08:00 ET | Source: NanoVibronix, Inc.

NanoVibronix Signs Major Distributor in India for UroShield®

ELMSFORD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
December 18, 2018 09:25 ET | Source: NanoVibronix, Inc.

NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®

ELMSFORD, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...